Generation Bio
GBIO5.3400.00% ( 0.000 )
Generation Bio (GBIO)
Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminat...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 5.340
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 7.601
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Generation Bio Analyst Rating
View MoreForecast & Rating
Jan 23, 2026Price forecast
$5.25-1.69%
Forecast & RatingHold
3analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- prnewswire · May 7 at 06:45 AM
07:45 ETAdvaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
- prnewswire · Apr 24 at 07:00 AM
08:00 ETCGBIO Receives FDA 510(k) Clearance for Patient-Specific Titanium Implant 'EASYMADE TI'
- TradingView · Apr 15 at 03:35 PM
Oncotelic Therapeutics 2025 10-K: Net income $249.02M; EPS $0.59
- WorldPharmaceuticals · Apr 10 at 04:25 AM
AllRock Bio begins patient dosing in Phase IIa ROCSTAR trial
- prnewswire · Apr 6 at 07:00 PM
20:00 ETCGBIO Showcases Comprehensive Medical Device Portfolio at KIMES 2026 Achieves KRW 5.3 Billion in Contract Results
- TechCrunch · Apr 3 at 03:30 PM
Anthropic buys biotech startup Coefficient Bio in $400M deal: reports
